Table 2: Showing WHO assessment scale, lab assessment, CT chest of the cases.
|
Case 1 |
Case 2 |
Case 3 |
Case 4 |
Case 5 |
Case 6 |
Case7 |
||||||||||||
Clinical status & performance |
WHO score 3 |
WHO score 1 |
WHO score 7 |
WHO score 4 |
WHO assessment score 1 |
WHO score 3 |
WHO score 2 |
||||||||||||
WBC |
10 |
12 |
12.5 |
8 |
5.2 |
3.9 |
5.7 |
||||||||||||
Lymphocyte count |
0.90 |
1.2 |
0.80 |
0.71 |
1.2 |
0.98 |
2.5 |
||||||||||||
D. Dimer |
0.69 |
0.15 |
|||||||||||||||||
Creatinine |
0.9 |
1.12 |
2.5 |
1.5 |
1.08 |
0.8 |
0.9 |
||||||||||||
Bilirubin (T) |
3.7 |
1.1 |
33 |
2.2 |
0.57 |
0.9 |
5 |
||||||||||||
ALT/ AST(U/L) |
33/36 |
45/55 |
43/53 |
210/118 |
55/54 |
15/7 |
112/125 |
||||||||||||
Ferritin |
500 |
550 |
1500 |
1029 |
107 |
120 |
100 |
||||||||||||
CRP (mg/dl) |
206 |
55 |
108 |
24 |
27.5 |
30.5 |
6.7 |
||||||||||||
Chest CT scan |
GGO (CORAD 3) |
GGO (CORAD 3) |
Bilateral GGO (CORAD 5) |
Bilateral GGO CORAD 5 |
NAD |
Subpleural faint opacity on one side (CORAD 1) |
Sub pleural faint opacity (CORAD 1) |
||||||||||||
SARS-CoV-2 real-time PCR |
Positive |
Positive |
Negative |
Positive |
Positive |
Positive |
Negative |
||||||||||||
Required hospitalization |
Yes |
No |
Yes |
Yes |
No |
Yes |
No |
||||||||||||
|
Case 8 |
Case 9 |
Case 10 |
Case 11 |
Case 12 |
Case 13 |
Case14 |
||||||||||||
Clinical status & performance |
WHO score 3 |
WHO score 3 |
WHO score 3 |
WHO score 2 |
WHO assessment score 1 |
WHO score 1 |
WHO score 1 |
||||||||||||
WBC |
2.5 |
10 |
12.5 |
7 |
8.5 |
3 |
7 |
||||||||||||
Lymphocyte count (%) |
0.10 |
2.5 |
0.98 |
0.75 |
2.1 |
1.9 |
2 |
||||||||||||
D. Dimer |
1.1 |
2.5 |
1.5 |
3.2 |
|||||||||||||||
Creatinine |
0.5 |
1 |
1.6 |
3.5 |
0.08 |
0.7 |
1.1 |
||||||||||||
Bilirubin (T) |
1.1 |
1.1 |
0.35 |
5.5 |
0.51 |
0.95 |
5 |
||||||||||||
ALT/ AST(U/L) |
12/25 |
42/15 |
43/53 |
550/102 |
42/20 |
11/20 |
500/250 |
||||||||||||
Ferritin |
324 |
890 |
1020 |
8059 |
25 |
220 |
1000 |
||||||||||||
CRP (mg/dl) |
142 |
155 |
86 |
240 |
20 |
30.5 |
6.7 |
||||||||||||
Chest CT scan |
GGO(CORAD 1) |
GGO(CORAD 2) |
Bilateral GGO (CORAD 5) |
Bilateral GGO CORAD 3 |
NAD |
NAD |
BILATERAL GCO(CORAD 4) |
||||||||||||
SARS-CoV-2 real-time PCR |
Negative |
Positive |
Negative |
Positive |
Positive |
Positive |
Negative |
||||||||||||
Required hospitalization |
Yes |
yes |
Yes |
managed at home |
No |
no |
No |
||||||||||||
|
Case 15 |
Case 16 |
Case 17 |
Case 18 |
Case 19 |
Case 20 |
Case21 |
||||||||||||
Clinical status & performance |
WHO score 4 |
WHO score 2 |
WHO score 3 |
WHO score 3 |
WHO assessment score 1 |
WHO score 2 |
WHO score 2 |
||||||||||||
WBC |
3.5 |
1.5 |
5.5 |
8 |
6.2 |
9.4 |
7.8 |
||||||||||||
Lymphocyte count |
0.28 |
1.1 |
0.77 |
1.71 |
2.2 |
0.55 |
3.1 |
||||||||||||
D. Dimer |
2.5 |
|
|||||||||||||||||
Creatinine |
1.5 |
1.1 |
1.9 |
2.4 |
0.08 |
1.5 |
1.9 |
||||||||||||
Bilirubin (T) |
1.1 |
1.2 |
0.33 |
0.25 |
0.55 |
0.19 |
2.5 |
||||||||||||
ALT/ AST(U/L) |
13/25 |
25/15 |
102/150 |
117/278 |
15/22 |
11/10 |
177/250 |
||||||||||||
Ferritin |
280 |
550 |
1000 |
2505 |
88 |
259 |
900 |
||||||||||||
CRP (mg/dl) |
206 |
55 |
108 |
24 |
27.5 |
30.5 |
6.7 |
||||||||||||
Chest CT scan |
GGO CORAD 5) |
GGO(CORAD 2) |
Bilateral GGO (CORAD 5) |
Bilateral GGO CORAD 5 |
NAD |
NAD |
Sub pleural faint opacity(CORAD 1) |
||||||||||||
SARS-CoV-2 real-time PCR |
Positive |
Positive |
POSITIVE |
Positive |
Positive |
Positive |
POSITIVE |
||||||||||||
Required hospitalization |
yes |
No |
Yes |
Yes |
No |
no |
No |
Abbreviations: CRP: C-Reactive Protein (< 5 mg/L); d: Day; D-dimer normal value < 500 ng/mL; FK: Tacrolimus; HCQ: Hydroxy Chloro Quine sulfate; MMF: Sodium Mycophenolate; Normal reference value of lymphocytes = 1.5-3.5 103/mm3; WBC: White Blood Cells (4-11 103/mm3).